Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome

Clinical trial NCT07328529 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07328529
Sponsor: Azevan Pharmaceuticals
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Aggressive Behavior in Fragile X Syndome

Start date: 2026-03-01
Primary completion: 2027-03-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.